This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Influenza A H17N10 Hemagglutinin (HA), N-His
Product Overview
BioVenic's Recombinant Influenza A H17N10 Hemagglutinin (HA), N-His is a recombinant protein expressed from E.coli Expression System. Its predicted molecular weight is 29.0 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
H17 is a phylogenetically distinct hemagglutinin identified in little yellow-shouldered bats.2 Unlike canonical HAs, the H17 protein possesses a highly acidic and distorted putative receptor-binding site (RBS) that does not bind traditional 3alpha 2,3- or 4 alpha 2,6-linked sialic acids.5 Emerging research suggests H17 may utilize MHC class II molecules as entry receptors instead of glycans.6 Despite these functional differences, it retains the typical trimeric Class I fusion protein structure, mediating viral internalisation and endosomal membrane fusion, making it a critical focus for bat-borne virus surveillance and cross-species transmission studies.
Shipping and Storage
This product is shipped with gel ice bags. Avoid repeated freezing and thawing. Store for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.